{'fraction_non_alphanumeric': 0.022401433691756272, 'fraction_numerical': 0.0062724014336917565, 'mean_word_length': 5.275280898876405, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Severe proliferative diabetic retinopathy associated with acromegaly

Acromegaly is complicated by diabetes mellitus because of the action of growth hormone (GH) which induces the production of insulin-like growth factor I (IGF-I). IGF-I may contribute to the development of diabetic retinopathy in an autocrine and/or paracrine manner.1 In patients with acromegaly who demonstrate excessive secretion of GH, the incidence of retinopathy is reportedly very low and severe retinopathy is rare.2 3 This report describes a patient with severe proliferative diabetic retinopathy in both eyes associated with acromegaly. We performed pars plana vitrectomy and calculated the levels of angiogenic growth factors (IGF-I and vascular endothelial growth factor, VEGF) in the vitreous of both eyes to learn whether GH and/or IGF-I may influence the progression of diabetic retinopathy in proliferative diabetic retinopathy associated with acromegaly.4 5 

### CASE REPORT

A 62 year old woman presented with severe proliferative diabetic retinopathy and was admitted to Osaka Kaisei Hospital for a pars plana vitrectomy. The …